DC4U

About:

DC4U is a life science company that develops technologies enabling steering the human immune response.

Website: http://www.dc4u-technologies.nl/

Top Investors: Eurostars, Eureka Network

Description:

DC4U is a life science company that develops technologies enabling steering the human immune response. Its core expertise is the immunological application of glycobiology. Based on this knowledge a platform technology (GlycoDC) was developed which can modulate the immune system and can be applied to antigen based therapeutics and products. Its GlycoDCTM technology can either potentiate or suppress the immune system via specific targeting of dendritic cells by glycan modified antigen conjugates.